Is hepatic transplantation justified for primary liver cancer?

被引:7
作者
Fisher, Robert A.
Maluf, Daniel G.
Wolfe, Luke
Williams, Bridgette
Cotterell, Adrian
Stravitz, R. Todd
Heuman, Douglas
Posner, Marc
机构
[1] Virginia Commonwealth Univ, Med Ctr, Dept Surg, Div Transplant Surg, Richmond, VA 23284 USA
[2] Virginia Commonwealth Univ, Med Ctr, Dept Med, Div Hepatol, Richmond, VA USA
关键词
HCC; liver transplantation; organ allocation; cancer free survival;
D O I
10.1002/jso.20617
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
A concise, yet objective overview of Hepatocellular Carcinoma (HCC) treatment in 2006 with an intent to transplant is presented. The most significant variables impacting on the use of hepatic transplantation as therapy for primary liver cancer are developed under the headings of: Staging Criteria; Organ allocation; Transplant dropout minimization therapies; and Effects on the HCC general population. The pertinent medical literature and update of an ongoing intent-to-treat HCC with transplant single center randomized control trial are reviewed.
引用
收藏
页码:674 / 679
页数:6
相关论文
共 30 条
[1]
[Anonymous], 1959, ORIGIN SPECIES MEANS
[2]
[Anonymous], INV BOOKL PROT
[3]
Non-resective ablation therapy for hepatocellular carcinoma: effectiveness measured by intention-to-treat and dropout from liver transplant waiting list [J].
Fisher, RA ;
Maluf, D ;
Cotterell, AH ;
Stravitz, T ;
Wolfe, L ;
Luketic, V ;
Sterling, R ;
Shiffman, M ;
Posner, M .
CLINICAL TRANSPLANTATION, 2004, 18 (05) :502-512
[4]
Hepatocellular carcinoma: strategy for optimizing surgical resection, transplantation and palliation [J].
Fisher, RA ;
Maroney, TP ;
Fulcher, AS ;
Maluf, D ;
Clay, JA ;
Wolfe, LG ;
Dawson, S ;
Cotterell, A ;
Stravitz, RT ;
Luketic, VA ;
Shiffman, M ;
Sterling, RK ;
Posner, MP .
CLINICAL TRANSPLANTATION, 2002, 16 :52-58
[5]
Improving liver allocation: MELD and PELD [J].
Freeman, RB ;
Wiesner, RH ;
Roberts, JP ;
McDiarmid, S ;
Dykstra, DM ;
Merion, RM .
AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 :114-131
[6]
The quandary over liver transplantation for hepatocellular carcinoma: The greater sin? [J].
Fung, J ;
Marsh, W .
LIVER TRANSPLANTATION, 2002, 8 (09) :775-777
[7]
External beam radiation therapy for hepatocellular carcinoma: Potential of intensity-modulated and image-guided radiation therapy [J].
Fuss, M ;
Salter, BJ ;
Herman, TS ;
Thomas, CR .
GASTROENTEROLOGY, 2004, 127 (05) :S206-S217
[8]
Chemoembolization followed by liver transplantation for hepatocellular carcinoma impedes tumor progression while on the waiting list and leads to excellent outcome [J].
Graziadei, IW ;
Sandmueller, H ;
Waldenberger, P ;
Koenigsrainer, A ;
Nachbaur, K ;
Jaschke, W ;
Margreiter, R ;
Vogel, W .
LIVER TRANSPLANTATION, 2003, 9 (06) :557-563
[9]
Harper A, 2005, AM J TRANSPLANT, V5, P564
[10]
Extended indications in living-donor liver transplantation: Bile duct cancer [J].
Jonas, S ;
Mittler, J ;
Pascher, A ;
Theruvath, T ;
Thelen, A ;
Klupp, J ;
Langrehr, JM ;
Neuhaus, P .
TRANSPLANTATION, 2005, 80 (01) :S101-S104